Evidence map›Paper›PMID 32091983›Full record

ArticleeLife2020

Large-scale cell-type-specific imaging of protein synthesis in a vertebrate brain.

Or David Shahar, Erin Margaret Schuman

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Or David ShaharMax Planck Institute for Brain Research, Frankfurt, Germany.ORCID 0000-0002-5039-8307
Erin Margaret SchumanMax Planck Institute for Brain Research, Frankfurt, Germany.ORCID 0000-0002-7053-1005
National Centre for Biological Sciences · IN

Funding

Deutsche Forschungsgemeinschaft CRC 1080Deutsche Forschungsgemeinschaft CRC 902European Molecular Biology Organization ALTF-643-2014Horizon 2020 Framework Programme 743216Seventh Framework Programme 628003
6 · The paper itself

Abstract

Despite advances in methods to detect protein synthesis, it has not been possible to measure endogenous protein synthesis levels in vivo in an entire vertebrate brain. We developed a transgenic zebrafish line that allows for cell-type-specific labeling and imaging of nascent proteins in the entire animal. By replacing leucine with glycine in the zebrafish MetRS-binding pocket (MetRS-L270G), we enabled the cell-type-specific incorporation of the azide-bearing non-canonical-amino-acid azidonorleucine (ANL) during protein synthesis. Newly synthesized proteins were then labeled via 'click chemistry'. Using a Gal4-UAS-ELAV3 line to express MetRS-L270G in neurons, we measured protein synthesis intensities across the entire nervous system. We visualized endogenous protein synthesis and demonstrated that seizure-induced neural activity results in enhanced translation levels in neurons. This method allows for robust analysis of endogenous protein synthesis in a cell-type-specific manner, in vivo at single-cell resolution.

Indexed as

AnimalsAnimals, Genetically ModifiedBrainNerve Tissue ProteinsZebrafishZebrafish ProteinsNerve Tissue ProteinsZebrafish Proteinscell biologycell type specificneuron specificneuroscienceprotein synthesistranslationtranslation controlzebrafish

Identifiers

PMID32091983
PMCPMC7048392
OpenAlexW3008797387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.